313 related articles for article (PubMed ID: 19796673)
1. Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects.
Cedazo-Minguez A; Winblad B
Exp Gerontol; 2010 Jan; 45(1):5-14. PubMed ID: 19796673
[TBL] [Abstract][Full Text] [Related]
2. [CSF biomarkers: proteomics investigations and clinical applications in neurodegenerative disorders].
Gabelle A; Roche S; Lehmann S
Rev Neurol (Paris); 2009 Mar; 165(3):213-22. PubMed ID: 18808768
[TBL] [Abstract][Full Text] [Related]
3. Clinical proteomics in neurodegenerative disorders.
Zetterberg H; Rüetschi U; Portelius E; Brinkmalm G; Andreasson U; Blennow K; Brinkmalm A
Acta Neurol Scand; 2008 Jul; 118(1):1-11. PubMed ID: 18279484
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease cerebrospinal fluid biomarker discovery: a proteomics approach.
D'Ascenzo M; Relkin NR; Lee KH
Curr Opin Mol Ther; 2005 Dec; 7(6):557-64. PubMed ID: 16372405
[TBL] [Abstract][Full Text] [Related]
5. CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment.
Blennow K
Expert Rev Mol Diagn; 2005 Sep; 5(5):661-72. PubMed ID: 16149870
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of Alzheimer's disease in body fluids.
Zheng Y; He J; Hong T
Sci China Life Sci; 2010 Apr; 53(4):490-6. PubMed ID: 20596916
[TBL] [Abstract][Full Text] [Related]
7. Imaging and biomarkers for Alzheimer's disease.
Allan CL; Sexton CE; Welchew D; Ebmeier KP
Maturitas; 2010 Feb; 65(2):138-42. PubMed ID: 20060241
[TBL] [Abstract][Full Text] [Related]
8. Recent cerebrospinal fluid biomarker studies of Alzheimer's disease.
Choi YS; Choe LH; Lee KH
Expert Rev Proteomics; 2010 Dec; 7(6):919-29. PubMed ID: 21142892
[TBL] [Abstract][Full Text] [Related]
9. Looking backward to move forward: early detection of neurodegenerative disorders.
DeKosky ST; Marek K
Science; 2003 Oct; 302(5646):830-4. PubMed ID: 14593169
[TBL] [Abstract][Full Text] [Related]
10. A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia.
Simonsen AH; McGuire J; Podust VN; Hagnelius NO; Nilsson TK; Kapaki E; Vassilopoulos D; Waldemar G
Dement Geriatr Cogn Disord; 2007; 24(6):434-40. PubMed ID: 17971664
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid tau, A beta, and phosphorylated tau protein for the diagnosis of Alzheimer's disease.
Formichi P; Battisti C; Radi E; Federico A
J Cell Physiol; 2006 Jul; 208(1):39-46. PubMed ID: 16447254
[TBL] [Abstract][Full Text] [Related]
12. Identifying early markers of Alzheimer's disease using quantitative multiplex proteomic immunoassay panels.
Soares HD; Chen Y; Sabbagh M; Roher A; Schrijvers E; Breteler M
Ann N Y Acad Sci; 2009 Oct; 1180():56-67. PubMed ID: 19906261
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers for the early detection of Parkinson's and Alzheimer's disease.
Berg D
Neurodegener Dis; 2008; 5(3-4):133-6. PubMed ID: 18322370
[TBL] [Abstract][Full Text] [Related]
14. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
[TBL] [Abstract][Full Text] [Related]
15. From proteomics to biomarker discovery in Alzheimer's disease.
Ho L; Sharma N; Blackman L; Festa E; Reddy G; Pasinetti GM
Brain Res Brain Res Rev; 2005 Apr; 48(2):360-9. PubMed ID: 15850675
[TBL] [Abstract][Full Text] [Related]
16. The role of proteomics in dementia and Alzheimer's disease.
Zellner M; Veitinger M; Umlauf E
Acta Neuropathol; 2009 Jul; 118(1):181-95. PubMed ID: 19259691
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers in geriatric psychiatry: searching for the holy grail?
Blumberger DM; Daskalakis ZJ; Mulsant BH
Curr Opin Psychiatry; 2008 Nov; 21(6):533-9. PubMed ID: 18852558
[TBL] [Abstract][Full Text] [Related]
18. CSF biomarkers for mild cognitive impairment and early Alzheimer's disease.
Andreasen N; Blennow K
Clin Neurol Neurosurg; 2005 Apr; 107(3):165-73. PubMed ID: 15823670
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers in preclinical Alzheimer's disease.
Chong MS; Lim WS; Sahadevan S
Curr Opin Investig Drugs; 2006 Jul; 7(7):600-7. PubMed ID: 16869111
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical dementia diagnostics: State of the art and research perspectives.
Lewczuk P; Wiltfang J
Proteomics; 2008 Mar; 8(6):1292-301. PubMed ID: 18271068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
